Viridian Therapeutics, Inc.\de
VRDN
Revenue
4.78M
▲3.59M▲301.34%
3 Months ChangeAssets
742.40M
▼-29.50M▼-3.82%
3 Months ChangeLiabilities
70.76M
▲6.36M▲9.88%
3 Months ChangeFree Cash Flow
-45.22M
▲16.87M▲27.16%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-09-12
Form 8-K
ID: 0001193125-24-218131
2024-09-10
Form 8-K
ID: 0001193125-24-216321
2024-08-08
Form 8-K
ID: 0001193125-24-196513
2024-08-08
Form 10-Q
ID: 0001590750-24-000019
2024-07-15
Form 8-K
ID: 0001193125-24-178820
2024-06-20
Form 8-K
ID: 0001193125-24-164461
2024-05-08
Form 10-Q
ID: 0001590750-24-000012
2024-05-08
Form 8-K
ID: 0001193125-24-133770
2024-04-16
Form 8-K
ID: 0001193125-24-097728
2024-02-27
Form 8-K
ID: 0001193125-24-047916